Reduced inhibitory potency of serotonin reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep

Biological Psychiatry

Volumn 40, Issue 10, 1996, Pages 1000-1007

  Maudhuit, Corinne ^a   Jolas, Thierry ^a   Chastanet, Michel ^a   Hamon, Michel ^a   Adrien, Joëlle ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

5 HT(1A) autoreceptor desensitization; REM sleep deprivation; serotonin

Indexed keywords

CERICLAMINE; CITALOPRAM; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; DEPRESSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; REM SLEEP; SLEEP DEPRIVATION;

EID: 0030589026     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00583-8     Document Type: Article

References (32)

1. Adrien J, Dugovic C (1984): Presence of paradoxical sleep factor in the cerebrospinal fluid of PS-deprived rats. Eur J Pharmacol 100:223-226.
2. Adrien J, Maudhuit C, Martin P (1992): Antidepressant-like effects of paradoxical sleep deprivation in the learned helplessness paradigm. J Sleep Res 1(suppl):2.
3. Aghajanian G (1982): Regulation of serotonergic neuronal activity: Autoreceptors and pacemaker potentials. Adv Biochem Psychopharmacol 34:173-181.
4. Artigas F, Perez V, Alvarez E (1994): Pindolol induces a rapid improvement of patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51:248-251.
5. Bel N, Artigas F (1993): Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243-245.
6. Blier P, de Montigny C, Chaput Y (1987): Modifications of the serotonin system by antidepressant treatments: Implication for the therapeutic response in major depression. J Clin Psychopharmacol 7:24S-35S.
7. Brebbia DR, Branchey MH, Pyne E, et al (1975): The effects of amoxapine on electroencephalographic stages of sleep in normal human subjects. Psychopharmacology 45:1-7.
8. Chaput Y, de Montigny C, Blier P (1986): Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 333:342-348.
9. Cramer H, Tagliamonte A, Tagliamonte P, et al (1973): Stimulation of brain serotonin turnover by paradoxical sleep deprivation in intact and hypophysectomized rats. Brain Res 54:372-375.
10. Ferrer A, Artigas F (1994): Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain. Eur J Pharmacol 263:227-234.
11. Fornal CA, Metzler SC, Veasey AC, et al (1994): Single unit recordings from freely-moving animals provide evidence that WAY-100635 but not (S)WAY-100135 blocks the action of endogenous serotonin at the 5-HT autoreceptor. Br J Pharmacol 112:92P.
12. 1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81-88.
13. Gillin JC, Wyatt RJ, Snyder F (1978): The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology 59: 267-272.
14. Héry F, Pujol JF, Lopez M, et al (1970): Increased synthesis and utilization of serotonin in the central nervous system of the rat during paradoxical sleep deprivation. Brain Res 21:391-403.
15. 1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharmacol Exp Ther 268:1432-1443.
16. Kafi de Saint Hilaire S, Merica H, Gaillard JM (1984): The effects of indalpine - a selective inhibitor of 5-HT uptake - on rat paradoxical sleep. Eur J Pharmacol 98:413-418.
17. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch Pharmacol 352:141-148.
18. Maudhuit C, Jolas T, Lainey E, et al (1994): Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat. Neuropharmacology 33: 1017-1025.
19. Maudhuit C, Hamon M, Adrien J (1995): Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. NeuroReport 6:681-684.
20. Michel F, Klein M, Jouvet D, Valatx JL (1961): Etude polygraphique du sommeil chez le rat. CR Soc Biol (Paris) 155:2389-2393.
21. Morden B, Mitchell G, Dement W (1967): Selective REM sleep deprivation and compensation phenomena in the rat. Brain Res 5:339-349.
22. Piñeyro G, Blier P, Dennis T, de Montigny C (1994): Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14:3036-3047.
23. Reyes RB, Hill SY, Kupfer DJ (1986): Effects of repeated zimelidine administration on sleep parameters in the rat. Psychopharmacology 88:54-57.
24. Rigdon GC, Wang CM (1991): Serotonin uptake blockers inhibit the firing of presumed serotonergic dorsal raphe neurons in vitro. Drug Dev Res 22:135-140.
25. Schechter L, Bolaños F, Gozlan H, et al (1990): Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: Biochemical and electrophysiological studies. J Pharmacol Exp Ther 255: 1335-1347.
26. Sommerfelt L (1990): Chronic zimelidine administration to cats: Sustained increase of serotoninergic effect as measured with sleep parameters. Pharmacol Toxicol 66:128-132.
27. Stern W, Miller F, Cox R, et al (1971): Brain norepinephrine and serotonin levels following REM sleep deprivation in the rat. Psychopharmacologia 22:50-55.
28. Vogel GW (1975): A review of REM sleep deprivation. Arch Gen Psychiatry 32:749-761.
29. Vogel GW, Thurmond AJ, Gibbons P, et al (1975): REM sleep reduction effects on depression syndromes. Arch Gen Psychiatry 32:765-777.
30. Vogel GW, Vogel F, McAbee RS, Thurmond AJ (1980): Improvement of depression by REM sleep deprivation. Arch Gen Psychiatry 37:247-253.
31. Willner P (1985): Antidepressants and serotonergic neurotransmission: An integrative review. Psychopharmacology 85: 387-404.
32. Wu JC, Bunney WE (1990): The biological basis of an antidepressant response to sleep deprivation and relapse: Review and hypothesis. Am J Psychiatry 147:14-21.